Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Wan Mark A, Director. Insider active across 2 companies, notably Acelrx Pharmaceuticals INC. In total, 5 filings have been recorded. Activity tracked since 17 June 2021. The latest transaction was disclosed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Mark A. Wan is a Board Member at AcelRx Pharmaceuticals Inc. He provides valuable expertise to the board, contributing to the strategy and governance of the company. His experience in the pharmaceutical sector is an asset to AcelRx.